Schizophrenia: One Name, Many Different Manifestations.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Schizophrenia is a severe mental disorder affecting about 1% of the global population.
• It manifests with positive symptoms (hallucinations, delusions), negative symptoms (apathy, lack of pleasure), and cognitive deficits.
• The etiology is complex, likely involving multiple environmental factors, neurotransmitters, and neurocircuits.

Purpose of the Study:

• To review the current understanding of schizophrenia's pathophysiology and treatment landscape.
• To highlight the limitations of existing therapies, particularly for negative and cognitive symptoms.
• To discuss emerging therapeutic strategies targeting alternative pathways.

Main Methods:

• Literature review of existing research on schizophrenia.
• Analysis of current pharmacologic treatments and their efficacy.
• Exploration of ongoing research into novel therapeutic targets.

Main Results:

• Dopamine receptor antagonists are effective for positive symptoms but show limited efficacy for negative and cognitive symptoms.
• The pathophysiology of schizophrenia is multifactorial, involving various neurotransmitter systems.
• Nondopaminergic medications and alternative receptor targets are under active investigation.

Conclusions:

• Current antipsychotic medications offer incomplete symptom control in schizophrenia.
• Further research is crucial for developing more effective treatments, especially for negative and cognitive domains.
• Integrated care combining pharmacotherapy with psychosocial support is essential for optimal patient management.